JOHN CUTHRIELL: Open Payments
NPI 1235991506 · CRESTVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 44 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $424 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $156 |
| Dexcom, Inc. | 3 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| ABBVIE INC. | 4 | $80 |
| PFIZER INC. | 4 | $77 |
| Biosense Webster, Inc. | 2 | $72 |
| Amgen Inc. | 3 | $50 |
| Exact Sciences Corporation | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: Dexcom G6 Transmitter, Ozempic, XIFAXAN, CARTO 3, Rybelsus, NURTEC ODT, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
